疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

9 c1 l7 s0 c7 M' K# x/ ]# WApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

1 [( Q3 ^9 D+ N( l. Z! nhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

! P; C/ I  V: I% n$ ISECTION 1: General aspects of vaccination
1 A short history of vaccination 1
8 M2 @# k* B+ g3 ?, ]; Z3 |2 Vaccine immunology 14
3 The vaccine industry 33
: ]/ Z6 ?6 Q" {# n4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 @: p0 Q1 L: b6 Vaccine additives and manufacturing residuals in the United States:
- w( [; k2 R% j; q# slicensed vaccines 71
; o  M4 V# I& s, ~$ s# i6 V5 [% A7 Passive immunization 80
8 i0 \- c, q# s* _8 General immunization practices 88
3 D2 ^5 `' J! o6 R! oSECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
( }/ L0 Z$ M5 V9 a+ I$ E$ R1 c11 Cholera vaccines 141
( }  W! H7 z) j  m% v6 f* q12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
# _; L4 f' Y9 Z) ~! l14 Hepatitis A vaccines 183
6 I8 S" S+ Q3 e$ X15 Hepatitis B vaccines 205
. k7 H8 x: y' y# e, ~& i16 Human papillomavirus vaccines 235
* S" s) b9 N% h. l9 z* ]& P% k; Y17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
& w- d0 F9 m  u) Z19 Japanese encephalitis vaccines 312
( E" w8 g/ N6 A6 y9 r20 Measles vaccines 352
: k3 L# n6 v9 Z- O$ Y21 Meningococcal vaccines 388
22 Mumps vaccine 419
- `! N6 ?2 R+ P: k7 D23 Pertussis vaccines . 447
5 Q6 q! Q+ r" P! I$ B24 Plague vaccines 493
# a8 X" I' U5 c) ]25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
$ T- Q* d( D) ~' H26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
. G! V) p7 ~: ~* `# H' n28 Poliovirus vaccine-live 598
8 C, {2 c2 B! n# o! Y" Q% `1 i29 Rabies vaccines .646
5 S4 X. S& w0 c8 H4 R: o9 r30 Rotavirus vaccines . 669
# s* p) c8 E$ ^7 ]* z- H+ ~31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
7 Y1 F; ]6 r2 m8 r+ }: p35 Tuberculosis vaccines 789
0 P  l1 Y( `* Y1 c. z36 Typhoid fever vaccines 812
6 M: z* S' j) c2 ?37 Varicella vaccine 837
) }7 C+ h0 A, F2 c1 I38 Yellow fever vaccine 870
( Z' y' a& M( k39 Zoster vaccine 969
40 Combination vaccines 981
; u3 J" a' o  KSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
8 x' A4 ?- G  Z0 h0 I43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
9 z0 N% n+ Q1 r- |: X" a45 Diarrhea caused by bacteria 1052
: ^: f6 s1 y4 g% r" b46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
$ U' N- @3 I/ R48 Hepatitis C vaccines 1074
6 [1 c( t, ?: P6 u' w; F% A49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
8 a% j' L) e8 q6 v5 x53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
6 b+ s! T4 c; n55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
4 }* p( P4 u1 p' K) N57 Staphylococcus aureus vaccines 1161
6 Z; `* c2 }5 `7 k5 H58 Streptococcus group A vaccines 1169
8 g' ~6 E: ?' F! m$ y59 Streptococcus group B vaccines 1176
/ p' g/ v1 |0 W1 z- Z! O60 Technologies for making new vaccines 1182
! R" a8 o) U5 }# F" F61 Alternative vaccine delivery methods 1200
2 F8 }9 F: j3 ?62 The development of gene-based vectors for immunization 1232
$ X- q5 n" G+ aSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
" o9 Q$ I% l$ k- a  @* u) M65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
* ?  |- ~0 T* P- j4 p. N! XSECTION 5: Public health and regulatory issues
# d  @3 X# z; a% l# j8 N1 ~67 Immunization in the United States 1310
68 Immunization in Europe . 1334
' @5 |* q/ M! Q. P! {: H69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
- W8 R$ H. a1 j! I" N9 K6 f72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
+ \2 a7 N; Z# J% T74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
3 j0 u0 r$ g/ q4 g77 Legal issues . 1481
( D/ L  w: Q; a/ n" y7 K. [78 Ethics 1508
" }% v2 e" D8 c, }

. t  q8 F1 A/ n; ?, j* p

1 {# y6 B4 K! k: p& I  q+ J

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
4 [5 ]5 K" [" A. d8 p) V* C
http://yun.baidu.com/share/link? ... 1&uk=3810996606

4 w' z- {' A+ i3 T1 ZSECTION 1: General aspects of vaccination
3 L5 ]9 W/ ]4 v1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
7 a9 |% t) V3 a; N0 Q% w* v4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
) @0 Q- O" ]" O% B( g6 X6 Vaccine additives and manufacturing residuals in the United States:
) [! ?# b; {4 j* e3 [4 Flicensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
- j5 h- c; D( I, d& `% L/ R8 tSECTION 2: Licensed vaccines
* j/ {+ j, l2 K8 S7 R% D: t% q9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
7 Q7 g: y9 `& m& S1 L8 c14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
+ E, H" S) {0 y9 u- |( E( k& [17 Inactivated influenza vaccines 257
1 {8 \8 T/ E: }) W( a) |7 |18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
9 T! h+ l0 R& C" \( j5 ~20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
- E1 e2 e: C* V23 Pertussis vaccines . 447
" r; ]+ L, }* L24 Plague vaccines 493
9 _  K% ^6 y/ I2 d1 |3 K25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
) M) F  K$ I. N0 N26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
. {' ~, F3 f' a$ ?, s( K30 Rotavirus vaccines . 669
% Z+ a* o5 c- ~31 Rubella vaccine 688
32 Smallpox and vaccinia 718
+ E& V" ?9 l1 C* F9 U/ M. m. ?6 U: T33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
) A  A$ o0 }7 C3 O5 R36 Typhoid fever vaccines 812
37 Varicella vaccine 837
; a  D: Y& S" b; ]" ?* V$ r+ S38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
( c- L6 a- c  y8 b; v7 O2 @SECTION 3: Vaccines in development and new vaccine strategies
3 U- i1 x2 n+ l41 Biodefense and special pathogen vaccines 1008
; E! O/ P3 Y8 i. O  |) [7 b2 l% y7 M42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
0 Z' m5 V# \4 @' E44 Dengue vaccines 1042
# `. K0 _( X2 w! `45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
6 k8 @4 t4 w, R0 i8 e- j48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
, b, y# \& g7 H9 w8 P50 Herpes simplex virus vaccines 1090
& i+ i- ?" {$ u: L2 L( S3 _( C51 Human immunodeficiency virus vaccines 1097
+ w1 _5 c8 e1 A2 M52 Lyme disease vaccines 1122
( ]) x; E2 A9 _$ b6 T( \53 Malaria vaccines 1133
, z  R7 M4 o0 L. z! T0 \  @) w54 Noninfectious disease vaccines 1138
$ I9 {* o% R2 y: ^55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
: I" h. a' e# l% U56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
1 l% F9 Z+ R, `- p7 H58 Streptococcus group A vaccines 1169
# J- E5 \6 t0 }5 n) W: c59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
9 _5 s! T& ]  ^' P2 M61 Alternative vaccine delivery methods 1200
8 i  O1 @) n; T6 c62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
4 f) Z/ ^. d# @/ S7 N4 j% n63 Vaccination of immunocompromised hosts 1243
2 }& N8 @( [- Q64 Vaccination of human immunodeficiency virus-infected persons 1257
6 O: F0 F: Z; S$ ^* T65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
0 A! Z5 k0 m  d8 ]  o- A& m6 FSECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
- L- L( p, A' p2 V- D69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
0 L, _' ]: W4 s! v1 b. g! S' q, k73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
1 T* z  }4 s9 J% Y75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508
, Y) r% g$ L0 n

casarett

Vaccines, 6e, 2012
( k4 r7 m/ [* w# p
Hardcover: 1570 pages
; {3 `; W: p1 _! nPublisher: Saunders; 6 edition (October 30, 2012)
Language: English
ISBN-10: 1455700908
! }0 |0 X- I6 h3 ?- Z; [Size: 52.3mb (original pdf)
: C8 d6 o* |1 R
2013 BMA Medical Book Awards Highly Commended in Public Health!
# e7 u" t; I5 E, r- F$ QApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
& E" O- {  t( E# }/ A  D% F
Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
: c7 {$ Z4 S: m' ?$ P$ f% G* \Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
2 |4 L! T! p1 S& k: W6 ~3 U* _; NGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
% W( V5 [! ?. l7 c; jAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
, z' L5 z: P8 G  nClearly visualize concepts and objective data through an abundance of tables and figures.
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
" o; ]6 k+ N- X$ X0 _' D6 }! gStay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
& P9 [" \/ R3 [" _& I0 X3 e8 a, L
. i+ Q; @4 \, o  ]8 l6 wDownload link: http://pan.baidu.com/s/1i5NxwLR
4 }" e9 \" b1 J6 S# v8 GCode for downloading: dv96
. Q  x( t1 X7 G5 i' K; M/ R. H